Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
Sukrithan V, Armbruster H, Rogers S, Vogt SM, Grenade C, Verschraegen C, Zhou Y, Goyal A, Natwa M, Hussein A, Barr H, Konate D, Batdorf R, Brown A, Williams B, Zhao S, Wei L, Xu M, Shah MH, Konda B.
Sukrithan V, et al. Among authors: xu m.
PLoS One. 2024 May 15;19(5):e0298824. doi: 10.1371/journal.pone.0298824. eCollection 2024.
PLoS One. 2024.
PMID: 38748739
Free PMC article.